Investigation on the levels of HbAlc in 396 non-diabetic patients with essential hypertension

CHEN Wei-dong,ZHANG Yi,YAN Yao-ming,XIAO Qin,ZHOU Wei
DOI: https://doi.org/10.3969/j.issn.1003-6350.2012.05.035
2012-01-01
Abstract:Objective To investigate the levels of HbAlc in non-diabetic patients with essential hypertension in Shenzhen City, and provide references for the reasonable treatment of the patients with essential hypertension. Methods Fasting plasma glucose (FPG), fasting insulin (Fins) and HbAlc were detected in 396 non-diabetic patients with essential hypertension without other diseases. The levels of HbAlc were compared in patients with essential hypertension alone (group Ⅰ), patients with essential hypertension and cardiac function grade Ⅰ~Ⅱ (group Ⅱ), as well as patients with hypertensive heart function grade Ⅲ (group Ⅲ). Results The average levels of FPG, FINS and HbAlc were in the three groups (5.93±2.37) mmol/L, (8.01±4.50) μU/ml and (6.75±1.44)%, respectively. FPG showed no statistically significant difference among the three groups (P>0.05). The average levels of Fins and HbAlc in group Ⅱ and group Ⅲ were significantly higher than those in group Ⅰ (P<0.05). Conclusion Nearly one third of the non-diabetic patients with essential hypertension living in Shenzhen City have elevated HbAlc level in varying degrees, and the elevated HbAlc level is one of the risk factors which associated with cardiac insufficiency.
What problem does this paper attempt to address?